Figure 3.
Kaplan–Meier survival analysis of low- and high-risk HCC patients by MMPM in cohort 2: overall survival (A), stratification of OS of cohort 2 for early TNM stage (I+II) (B), and tumour size <5 cm (C), recurrence-free survival (D), stratification of RFS for early TNM stage (I+II) (E) and tumour size <5 cm (F).